Mark-Bram Bouman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark-Bram Bouman has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Margriet Gezina Mullender
Department of Plastic, Reconstructive and Hand Surgery, Amsterdam UMC, Location VUmc
9 shared publications - Garry Lester Sergio Pigot
Afdeling Urologie, Amsterdam UMC, Locatie VUmc, Amsterdam, Nederland
6 shared publications - Freek P. W. de Rooij
Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands
4 shared publications - Wouter B. van der Sluis
Department of Plastic, Reconstructive and Hand Surgery, Amsterdam University Medical Center
4 shared publications - Florence A. C. J. Heijsters
Amsterdam UMC, Department of Plastic, Reconstructive and Hand Surgery, Amsterdam, the Netherlands; Amsterdam UMC, Department of Strategy and Innovation, Amsterdam, the Netherlands; Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands
3 shared publications - Floyd W. Timmermans
Department of Plastic, Reconstructive and Hand Surgery, Amsterdam University Medical Center, location VUMC, Amsterdam, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (12)
Technical variation and evidence maturity in gender-affirming peritoneal vaginoplasty: a systematic review
Background: Peritoneal vaginoplasty is increasingly being adopted within feminizing genital gender-affirming surgery. However, the way and extent to which peritoneum is used for vaginal lining varies considerably, and the term “peritoneal vaginoplasty” appears to encompass several technically distinct procedures. Aim: To assess technical variation and surgical indications in gender-affirming peritoneal vaginoplasty, and evaluate evidence maturity through the lens of the Idea, Development, Exploration, Assessment and Long-term study (IDEAL) framework. Methods: A systematic search identified studies reporting use of peritoneum in gender-affirming vaginoplasty. Data on surgical characteristics and indications were extracted as primary outcomes and data on evidence maturity as secondary outcomes. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed, and risk of bias was assessed using Joanna Briggs Institute checklists. Outcomes: Primary outcomes were technical characteristics, including flap number, configuration, vascularization, extent of vaginal lining, surgical indication, postoperative management, and reported outcomes. Secondary outcomes included study design, rationale for innovation, prospective registration, informed consent, outcome selection, outcome measures, and IDEAL stage. Results: Of 1425 screened records, 23 full-text and five video articles were included, representing 14 centers. Techniques were categorized into four groups based on peritoneal flap number, configuration, and vascularization. Substantial heterogeneity was observed in technical characteristics, surgical indications, and postoperative management. Techniques were largely center-specific, and indications ranged from routine use in primary vaginoplasty to genital skin deficiency, patient preference, and secondary reconstruction. No included publication reported prospective registration or referred to a published protocol. Informed consent was reported in six studies. Rationale for innovation, outcome selection, and technical choices was absent or limited. Safety was the predominant outcome, with 22 of 23 full-text studies reporting complications, whereas only three included survey-based patient-reported outcomes. Two studies were most consistent with IDEAL stage 2a. The remaining studies could not be staged. Clinical implications: Peritoneal vaginoplasty should not be regarded as a single intervention. Technique- and indication-specific evaluation is needed to identify which patients may benefit most from each approach and in whom specific techniques may be inappropriate or contraindicated. Strengths and limitations: Strengths include the comprehensive technical overview and structured evaluation using IDEAL. Limitations include incomplete reporting, probable participant overlap, and heterogeneity precluding pooled outcome synthesis. Conclusion: Peritoneal vaginoplasty comprises a heterogeneous group of techniques rather than a standardized procedure. Technical variation, differing indications, and heterogeneous outcome reporting preclude clinically meaningful comparison of safety and effectiveness. Prospective, technique- and indication-specific studies are required to determine the clinical role of individual techniques.
- 6 November 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (12)
Open AccessTechnical variation and evidence maturity in gender-affirming peritoneal vaginoplasty: a systematic review
Background: Peritoneal vaginoplasty is increasingly being adopted within feminizing genital gender-affirming surgery. However, the way and extent to which peritoneum is used for vaginal lining varies considerably, and the term “peritoneal vaginoplasty” appears to encompass several technically distinct procedures. Aim: To assess technical variation and surgical indications in gender-affirming peritoneal vaginoplasty, and evaluate evidence maturity through the lens of the Idea, Development, Exploration, Assessment and Long-term study (IDEAL) framework. Methods: A systematic search identified studies reporting use of peritoneum in gender-affirming vaginoplasty. Data on surgical characteristics and indications were extracted as primary outcomes and data on evidence maturity as secondary outcomes. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed, and risk of bias was assessed using Joanna Briggs Institute checklists. Outcomes: Primary outcomes were technical characteristics, including flap number, configuration, vascularization, extent of vaginal lining, surgical indication, postoperative management, and reported outcomes. Secondary outcomes included study design, rationale for innovation, prospective registration, informed consent, outcome selection, outcome measures, and IDEAL stage. Results: Of 1425 screened records, 23 full-text and five video articles were included, representing 14 centers. Techniques were categorized into four groups based on peritoneal flap number, configuration, and vascularization. Substantial heterogeneity was observed in technical characteristics, surgical indications, and postoperative management. Techniques were largely center-specific, and indications ranged from routine use in primary vaginoplasty to genital skin deficiency, patient preference, and secondary reconstruction. No included publication reported prospective registration or referred to a published protocol. Informed consent was reported in six studies. Rationale for innovation, outcome selection, and technical choices was absent or limited. Safety was the predominant outcome, with 22 of 23 full-text studies reporting complications, whereas only three included survey-based patient-reported outcomes. Two studies were most consistent with IDEAL stage 2a. The remaining studies could not be staged. Clinical implications: Peritoneal vaginoplasty should not be regarded as a single intervention. Technique- and indication-specific evaluation is needed to identify which patients may benefit most from each approach and in whom specific techniques may be inappropriate or contraindicated. Strengths and limitations: Strengths include the comprehensive technical overview and structured evaluation using IDEAL. Limitations include incomplete reporting, probable participant overlap, and heterogeneity precluding pooled outcome synthesis. Conclusion: Peritoneal vaginoplasty comprises a heterogeneous group of techniques rather than a standardized procedure. Technical variation, differing indications, and heterogeneous outcome reporting preclude clinically meaningful comparison of safety and effectiveness. Prospective, technique- and indication-specific studies are required to determine the clinical role of individual techniques.
- 3 July 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (8)
Single-stage phalloplasty with urethral lengthening using a pedicled SCIP-based flap for shaft reconstruction and RFFF for urethral reconstruction: description of our surgical technique and initial outcomes
- 3 July 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (8)
Single-stage phalloplasty with urethral lengthening using a pedicled SCIP-based flap for shaft reconstruction and RFFF for urethral reconstruction: description of our surgical technique and initial outcomes
- Open Access
- 7 November 2025
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (1)
The surgical treatment of introital stenosis after vaginoplasty in transgender women: 35 years of experience
- 7 November 2025
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (1)
Open AccessThe surgical treatment of introital stenosis after vaginoplasty in transgender women: 35 years of experience
- Open Access
- 3 July 2025
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 204, 106032
Process evaluation of the implementation of a personalized digital care pathway tool using the RE-AIM framework
- 3 July 2025
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 204, 106032
Open AccessProcess evaluation of the implementation of a personalized digital care pathway tool using the RE-AIM framework
- Open Access
- 17 September 2024
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 26 (2) , 464-473
Gender-affirming surgeries and patient-reported outcomes in gender binary versus non-binary and genderqueer-identifying individuals
- 17 September 2024
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 26 (2) , 464-473
Open AccessGender-affirming surgeries and patient-reported outcomes in gender binary versus non-binary and genderqueer-identifying individuals
- Open Access
- 10 September 2024
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 26 (2) , 459-463
Gender-affirming orchiectomy in transgender and non-binary individuals: A large cohort study with middle- to long-term follow-up
Some transgender individuals opt for gender-affirming orchiectomy. Data on postoperative outcomes in the transgender population are scarce. All individuals who underwent gender-affirming orchiectomy between 01-2010 and 01-2024 were retrospectively identified at two centers that provide surgical transgender care. Individual demographics, motivations, intra- and postoperative complications, reoperations and postoperative regret were recorded. Surgical risk factors were identified using logistic regression analysis. A total of 119 individuals were retrospectively identified with a median clinical follow-up of 2.3 years (range 0.3–9.4). A total of 109 identified as transgender woman, eight as non-binary and two as agender. 18 (15%) individuals opted for sperm cryopreservation before surgery. The postoperative course was without complications in 102 (86%) individuals. Complications comprised hemorrhage (n = 5, 4%, Clavien-Dindo 3b) and abscess formation (n = 7, 6%, Clavien-Dindo 2), (n = 1), 3a (n = 3) and 3b (n = 3))). In the follow-up time, seven individuals underwent vaginoplasty, two vulvoplasty and two were on the waiting list for vaginoplasty. There were no cases of regret. A BMI >35 was identified as risk factor for infectious complications (p = .045, OR 9.8, 95% CI 1.0–99.3). Gender-affirming orchiectomy is a simple and safe procedure. It can be performed as standalone gender-affirming surgical procedure, or as bridge to another gender-affirming procedure.
- 10 September 2024
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 26 (2) , 459-463
Open AccessGender-affirming orchiectomy in transgender and non-binary individuals: A large cohort study with middle- to long-term follow-up
Some transgender individuals opt for gender-affirming orchiectomy. Data on postoperative outcomes in the transgender population are scarce. All individuals who underwent gender-affirming orchiectomy between 01-2010 and 01-2024 were retrospectively identified at two centers that provide surgical transgender care. Individual demographics, motivations, intra- and postoperative complications, reoperations and postoperative regret were recorded. Surgical risk factors were identified using logistic regression analysis. A total of 119 individuals were retrospectively identified with a median clinical follow-up of 2.3 years (range 0.3–9.4). A total of 109 identified as transgender woman, eight as non-binary and two as agender. 18 (15%) individuals opted for sperm cryopreservation before surgery. The postoperative course was without complications in 102 (86%) individuals. Complications comprised hemorrhage (n = 5, 4%, Clavien-Dindo 3b) and abscess formation (n = 7, 6%, Clavien-Dindo 2), (n = 1), 3a (n = 3) and 3b (n = 3))). In the follow-up time, seven individuals underwent vaginoplasty, two vulvoplasty and two were on the waiting list for vaginoplasty. There were no cases of regret. A BMI >35 was identified as risk factor for infectious complications (p = .045, OR 9.8, 95% CI 1.0–99.3). Gender-affirming orchiectomy is a simple and safe procedure. It can be performed as standalone gender-affirming surgical procedure, or as bridge to another gender-affirming procedure.
- Open Access
- 16 August 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (5) , e1411-e1419
Shaping the Skeleton: Impact of GnRH Analogue and Sex Hormone Therapy on Skeletal Dimensions in Transgender Individuals
Context Skeletal dimensions vary between sexes. Men typically have broader shoulders and women a wider pelvis. If gender affirming hormone therapy (GAHT) with or without prior puberty suppression (PS) alters these dimensions in transgender individuals remains unclear. Objective To investigate impact of PS and GAHT on skeletal dimensions. Design Retrospective cross-sectional study. Setting Gender identity clinic. Participants Transgender individuals assigned male at birth (AMAB) and assigned female at birth (AFAB) who underwent dual-energy X-ray absorptiometry (DXA) scanning between ages 18 and 28 years were divided into four groups: Early PS (Tanner G/B2-3)+GAHT, Late PS (Tanner G/B4-5)+GAHT, GAHT only, and Untreated. Main outcome measures Shoulder and pelvis dimensions measured by DXA scan were compared between groups, with adjustment for height. Results A total of 121 individuals AMAB and 122 AFAB were included. Only in individuals AMAB who underwent early PS had smaller shoulders compared to untreated individuals AMAB (-1.3 cm; 95%CI -2.1; -0.5). In individuals AMAB from both the early and late PS group, pelvic inlet, pubic symphysis width and interischial distance were greater compared to untreated individuals AMAB resulting in dimensions comparable to untreated individuals AFAB. Only in early PS AFAB pelvic inlet width was smaller compared to untreated individuals AFAB (-1.0 cm; 95%CI -1.5; -0.6), and comparable to untreated individuals AMAB. Conclusions The study results suggest that skeletal dimensions are only altered by GAHT if endogenous puberty has not yet been completed at start of PS. These findings enhance our understanding of hormonal effects on the skeleton and may hold clinical relevance for body image as well as for forensic anthropology. Future research should evaluate clinical implications for surgical or obstetrical outcomes in transgender individuals.
- 16 August 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (5) , e1411-e1419
Open AccessShaping the Skeleton: Impact of GnRH Analogue and Sex Hormone Therapy on Skeletal Dimensions in Transgender Individuals
Context Skeletal dimensions vary between sexes. Men typically have broader shoulders and women a wider pelvis. If gender affirming hormone therapy (GAHT) with or without prior puberty suppression (PS) alters these dimensions in transgender individuals remains unclear. Objective To investigate impact of PS and GAHT on skeletal dimensions. Design Retrospective cross-sectional study. Setting Gender identity clinic. Participants Transgender individuals assigned male at birth (AMAB) and assigned female at birth (AFAB) who underwent dual-energy X-ray absorptiometry (DXA) scanning between ages 18 and 28 years were divided into four groups: Early PS (Tanner G/B2-3)+GAHT, Late PS (Tanner G/B4-5)+GAHT, GAHT only, and Untreated. Main outcome measures Shoulder and pelvis dimensions measured by DXA scan were compared between groups, with adjustment for height. Results A total of 121 individuals AMAB and 122 AFAB were included. Only in individuals AMAB who underwent early PS had smaller shoulders compared to untreated individuals AMAB (-1.3 cm; 95%CI -2.1; -0.5). In individuals AMAB from both the early and late PS group, pelvic inlet, pubic symphysis width and interischial distance were greater compared to untreated individuals AMAB resulting in dimensions comparable to untreated individuals AFAB. Only in early PS AFAB pelvic inlet width was smaller compared to untreated individuals AFAB (-1.0 cm; 95%CI -1.5; -0.6), and comparable to untreated individuals AMAB. Conclusions The study results suggest that skeletal dimensions are only altered by GAHT if endogenous puberty has not yet been completed at start of PS. These findings enhance our understanding of hormonal effects on the skeleton and may hold clinical relevance for body image as well as for forensic anthropology. Future research should evaluate clinical implications for surgical or obstetrical outcomes in transgender individuals.
- Open Access
- 18 January 2024
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 62 (5) , 853-862
What Parents of Children Born with a Cleft Lip and/or Palate Want to Know About the Care for their Child
Objective: Adequate health information that matches the needs of care recipients is a prerequisite for patient-centered care. To facilitate the provision of tailored and timely information, it isimportant to understand the information needs of parents of children and adolescents with cleft lip and/or palate (CL/P) themselves, and in addition they were asked how they experienced the provided care-related information. Design: A cross-sectional study employing questionnaires and semi-structured interviews. Setting: Participants were recruited from a cleft palate-craniofacial care unit in a major tertiary hospital in the Netherlands. Participants: Participants were parents or guardians of children with CL/P, and two adolescents with CLP. They were recruited through the outpatient clinic during multidisciplinary consultation or after clinical admission. Results: In total, fifty-five questionnaires were completed by parents or guardians and eleven interviews were conducted with nine parents of children with CL/P and two adolescents with CL/P. In general, participants reported to be satisfied with provided information during hospital admission or multidisciplinary cleft team consultations (mean 8.0, scale 0–10). In addition, 25.5% (n = 14) indicated that information to prepare for hospital admission was lacking (eg, practical information). Thematic qualitative analysis yielded five main information needs: 1) Clear communication during the care process, 2) Overview of the care trajectory, 3) Specific care plan information, 4) Presentation of information and 5) Guidance and support. Conclusions: Our findings emphasize the importance of gaining insights into wishes and information needs from care recipients who can provide insights in their information needs. With these findings, information provision should be redesigned to improve and to foster the further transition to family-centered care.
- 18 January 2024
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 62 (5) , 853-862
Open AccessWhat Parents of Children Born with a Cleft Lip and/or Palate Want to Know About the Care for their Child
Objective: Adequate health information that matches the needs of care recipients is a prerequisite for patient-centered care. To facilitate the provision of tailored and timely information, it isimportant to understand the information needs of parents of children and adolescents with cleft lip and/or palate (CL/P) themselves, and in addition they were asked how they experienced the provided care-related information. Design: A cross-sectional study employing questionnaires and semi-structured interviews. Setting: Participants were recruited from a cleft palate-craniofacial care unit in a major tertiary hospital in the Netherlands. Participants: Participants were parents or guardians of children with CL/P, and two adolescents with CLP. They were recruited through the outpatient clinic during multidisciplinary consultation or after clinical admission. Results: In total, fifty-five questionnaires were completed by parents or guardians and eleven interviews were conducted with nine parents of children with CL/P and two adolescents with CL/P. In general, participants reported to be satisfied with provided information during hospital admission or multidisciplinary cleft team consultations (mean 8.0, scale 0–10). In addition, 25.5% (n = 14) indicated that information to prepare for hospital admission was lacking (eg, practical information). Thematic qualitative analysis yielded five main information needs: 1) Clear communication during the care process, 2) Overview of the care trajectory, 3) Specific care plan information, 4) Presentation of information and 5) Guidance and support. Conclusions: Our findings emphasize the importance of gaining insights into wishes and information needs from care recipients who can provide insights in their information needs. With these findings, information provision should be redesigned to improve and to foster the further transition to family-centered care.
- Open Access
- 15 December 2023
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 26 (1) , 78-87
The GenderCOS project: study protocol for the development of two international Core Outcome Sets for genital gender affirming surgery
Aims: This international consensus study aims to develop Core Outcome Sets (COS) for both masculinizing and feminizing gGAS. These represent the minimum sets of outcomes recommended to be measured and reported in all clinical trials pertaining to gGAS. Methods: Two Core Outcome Sets for masculinizing and feminizing gGAS will be developed in parallel by following the Core Outcome Measures in Effectiveness Trials (COMET) guidelines. The stages of development for each set are: i) Identify outcomes measured and reported in previous research through a systematic review of the literature; ii) Identify outcomes suggested by transgender and gender diverse individuals during focus groups and interviews; iii) Combine and structure the outcomes into a preliminary outcome list; iv) Conduct e-Delphi surveys among stakeholders (i.e. professionals in transgender healthcare and transgender individuals) in which all potential outcomes will be rated on level of importance; and v) Decide on the final COS during an online consensus meeting. Discussion: This study will produce minimum, core sets of relevant outcomes for gGAS, through reaching international consensus with key stakeholders, including transgender individuals. Development of these COS will enable the measurement and reporting of relevant and standardized outcomes, facilitating continued scientific advancement of this field.
- 15 December 2023
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 26 (1) , 78-87
Open AccessThe GenderCOS project: study protocol for the development of two international Core Outcome Sets for genital gender affirming surgery
Aims: This international consensus study aims to develop Core Outcome Sets (COS) for both masculinizing and feminizing gGAS. These represent the minimum sets of outcomes recommended to be measured and reported in all clinical trials pertaining to gGAS. Methods: Two Core Outcome Sets for masculinizing and feminizing gGAS will be developed in parallel by following the Core Outcome Measures in Effectiveness Trials (COMET) guidelines. The stages of development for each set are: i) Identify outcomes measured and reported in previous research through a systematic review of the literature; ii) Identify outcomes suggested by transgender and gender diverse individuals during focus groups and interviews; iii) Combine and structure the outcomes into a preliminary outcome list; iv) Conduct e-Delphi surveys among stakeholders (i.e. professionals in transgender healthcare and transgender individuals) in which all potential outcomes will be rated on level of importance; and v) Decide on the final COS during an online consensus meeting. Discussion: This study will produce minimum, core sets of relevant outcomes for gGAS, through reaching international consensus with key stakeholders, including transgender individuals. Development of these COS will enable the measurement and reporting of relevant and standardized outcomes, facilitating continued scientific advancement of this field.
- Open Access
- 31 October 2023
- Published by Elsevier in F&S Reviews
- Vol. 4 (4) , 219-236
Vaginoplasty for gender dysphoria and Mayer–Rokitansky–Küster–Hauser syndrome: a systematic review
- 31 October 2023
- Published by Elsevier in F&S Reviews
- Vol. 4 (4) , 219-236
Open AccessVaginoplasty for gender dysphoria and Mayer–Rokitansky–Küster–Hauser syndrome: a systematic review